Kenji Horiuchi

Title: Kenji Horiuchi: Innovator in Pharmaceutical Chemistry

Introduction

Kenji Horiuchi is a notable inventor based in Daito, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. With a total of 2 patents to his name, Horiuchi's work focuses on innovative solutions for health-related issues.

Latest Patents

Horiuchi's latest patents include groundbreaking research on pyrimidine and pyridine derivatives. These compounds are represented by a specific general formula and have shown an inhibitory effect on acyl-CoA:cholesterol O-acyltransferase (ACAT). This invention not only details the production process of these compounds but also outlines their potential uses in medical applications. Another significant patent involves N-heteroaryl-N'-phenylurea derivatives, which are useful as prophylactic and therapeutic agents for conditions such as hypercholesterolemia and atherosclerosis.

Career Highlights

Horiuchi is currently employed at Nihon Nohyaku Co., Ltd., where he continues to advance his research in pharmaceutical chemistry. His work has been instrumental in developing new therapeutic agents that address critical health challenges.

Collaborations

Throughout his career, Horiuchi has collaborated with esteemed colleagues, including Masanori Yoshida and Yoshimitsu Matsui. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Kenji Horiuchi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in therapeutic solutions.